Research prioritisation in preparedness for and response to outbreaks of high-consequence pathogens: a scoping review
Antonio E. et al, (2025), BMC Medicine, 23
A protocol for a living mapping review of global research funding for infectious diseases with a pandemic potential – Pandemic PACT
Seminog O. et al, (2024), Wellcome Open Research, 9, 156 - 156
Scoping review protocol on research prioritisation for preparedness and response to outbreaks of high consequence pathogens
Antonio E. et al, (2024), Open Research Europe, 3, 16 - 16
A protocol for a living mapping review of global research funding for infectious diseases with a pandemic potential – PANDEMIC PACT
Seminog O. et al, (2024), Wellcome Open Research, 9, 156 - 156
Improving coherence of global research funding: Pandemic PACT
Norton A. et al, (2024), The Lancet, 403, 1233 - 1233
Funding and COVID-19 research in Africa: two years on, are the research needs of Africa being met?
Antonio E. et al, (2023), Open Research Africa, 6, 16 - 16
A review of new challenges and solutions to the timely and effective implementation of clinical research responses to high priority diseases of epidemic and pandemic potential: A scoping review protocol
Kadri-Alabi Z. et al, (2023), Open Research Europe, 3, 139 - 139
A living mapping review for COVID-19 funded research projects: final (27 month) update
Bucher A. et al, (2023), Wellcome Open Research, 5, 209 - 209
How funders can support improved clinical trial practice for outbreaks.
Foster I. et al, (2023), Lancet (London, England), 402
A living mapping review for COVID-19 funded research projects: two year update
Bucher A. et al, (2023), Wellcome Open Research, 5, 209 - 209
Scoping review protocol on research prioritisation for preparedness and response to outbreaks of high consequence pathogens
Antonio E. et al, (2023), Open Research Europe, 3, 16 - 16
Scoping review protocol on research prioritisation for preparedness and response to outbreaks of high consequence pathogens.
Antonio E. et al, (2023), Open research Europe, 3
Severe acute hepatitis of unknown aetiology in children—what is known?
Khader S. et al, (2022), BMC Medicine, 20
Sudan virus disease outbreak in Uganda: urgent research gaps
Ibrahim SK. et al, (2022), BMJ Global Health, 7, e010982 - e010982
A living mapping review for COVID-19 funded research projects: 21 month update
Bucher A. et al, (2022), Wellcome Open Research, 5, 209 - 209
A living mapping review for COVID-19 funded research projects: 18 month update
Bucher A. et al, (2022), Wellcome Open Research, 5, 209 - 209
Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review
Webb E. et al, (2022), BMJ Global Health, 7, e009838 - e009838
A living mapping review for COVID-19 funded research projects: one year update
Norton A. et al, (2022)
A living mapping review for COVID-19 funded research projects: nine-month update
Norton A. et al, (2021), Wellcome Open Research, 5, 209 - 209
Long COVID: tackling a multifaceted condition requires a multidisciplinary approach
Norton A. et al, (2021), The Lancet Infectious Diseases, 21, 601 - 602
Priorities for COVID-19 research response and preparedness in low-resource settings
Norton AJ. et al, (2021), The Lancet, 397, 1866 - 1868
A living mapping review for COVID-19 funded research projects: six-month update
Norton A. et al, (2021), Wellcome Open Research, 5, 209 - 209
Correction to Lancet Infect Dis 2021; online Feb 3. https://doi.org/10.1016/S1473-3099(21)00043-8.
(2021), The Lancet. Infectious diseases, 21
A living mapping review for COVID-19 funded research projects: three-month update
Norton A. et al, (2020), Wellcome Open Research, 5, 209 - 209
Baseline results of a living systematic review for COVID-19 funded research projects
Norton A. et al, (2020), Wellcome Open Research, 5, 209 - 209
Strengthening the global effort on COVID-19 research
Norton A. et al, (2020), The Lancet, 396, 375 - 375
The remaining unknowns: a mixed methods study of the current and global health research priorities for COVID-19.
Norton A. et al, (2020), BMJ global health, 5
A living mapping review for COVID-19 funded research projects: 18 month update.
Bucher A. et al, (2020), Wellcome open research, 5
Funding and COVID-19 research priorities - are the research needs for Africa being met?
Antonio E. et al, (2020), AAS open research, 3
Two-year longitudinal survey reveals high genetic diversity of Schistosoma mansoni with adult worms surviving praziquantel treatment at the start of mass drug administration in Uganda.
Faust CL. et al, (2019), Parasites & vectors, 12
POPULATION GENETICS OF SCHISTOSOME PARASITES IN SCHOOL AGED CHILDREN BEFORE AND AFTER PRAZIQUANTEL TREATMENT
Faust C. et al, (2018), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 99, 19 - 19
Population genetic structure of Schistosoma mansoni and Schistosoma haematobium from across six sub-Saharan African countries: implications for epidemiology, evolution and control.
Gower CM. et al, (2013), Acta tropica, 128, 261 - 274
Reductions in genetic diversity of Schistosoma mansoni populations under chemotherapeutic pressure: the effect of sampling approach and parasite population definition.
French MD. et al, (2013), Acta tropica, 128, 196 - 205
The impact of single versus mixed Schistosoma haematobium and S. mansoni infections on morbidity profiles amongst school-children in Taveta, Kenya.
Gouvras AN. et al, (2013), Acta tropica, 128, 309 - 317
Genetic consequences of mass human chemotherapy for Schistosoma mansoni: population structure pre- and post-praziquantel treatment in Tanzania.
Norton AJ. et al, (2010), The American journal of tropical medicine and hygiene, 83, 951 - 957
Simultaneous infection of Schistosoma mansoni and S. rodhaini in Biomphalaria glabrata: impact on chronobiology and cercarial behaviour.
Norton A. et al, (2008), Parasites & vectors, 1
IMPLICATIONS OF THE EFFECT OF SCHISTOSOMA MANSONI AND SCHISTOSOMA HAEMATOBIUM CO-INFECTIONS ON HUMAN MORBIDITY INDICATORS
Gouvras AN. et al, (2008), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 79, 90 - 90
THE EFFECT OF PRAZIQUANTEL TREATMENT ON THE GENETIC DIVERSITY OF SCHISTOSOMA MANSONI INFECTIONS IN PRIMARY SCHOOL CHILDREN WITHIN MAYUGE DISTRICT, UGANDA
Lamberton PH. et al, (2008), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 79, 222 - 222
Inter-specific parasite competition: mixed infections of Schistosoma mansoni and S. rodhaini in the definitive host.
Norton AJ. et al, (2008), Parasitology, 135, 473 - 484
Evolutionary concepts in predicting and evaluating the impact of mass chemotherapy schistosomiasis control programmes on parasites and their hosts.
Webster JP. et al, (2008), Evolutionary applications, 1, 66 - 83